May 15, 2012 - Myeloma Treatment and Side Effects Management Update
Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.
Date: May 15, 2012
Time: 12:30 p.m. - 2:00 p.m. ET
Location: Telephone/Web
Read: Myeloma News | Noticias sobre el mieloma | Transcript
Download: Program Slides
Listen: Presentation | Q&A Session | Presentation/Q&A Session (Spanish)
Access: Virtual Lecture (English/Spanish)
Topics Covered
- Current and emerging treatment options for myeloma
- The importance of clinical trials in improving myeloma patient outcomes
- Possible myeloma symptoms and treatment for side effects management
- Survivorship issues for people living with myeloma
Speakers
Melissa Alsina, MD
Head, Multiple Myeloma Program
Associate Member, Department of Blood & Marrow Transplantation
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL
Kathy A. Daily, RN, OCN
Multiple Myeloma Bone Marrow Transplant Coordinator/Primary Nurse
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL
Questions Asked by the Myeloma Community
- What is the name of the blood test used to determine the aggressiveness of myeloma?
- Can you explain intravenous immunoglobulins?
- What is considered complete remission?
- Which drug, lenalidomide (Revlimid®) or dexamethasone, will lower platelets, lower white cells and lower blood protein? Which drug damages the good cells as well as the bad cells?
- Are there treatment options that won't make someone's neuropathy worse?
- If someone has IgA myeloma, and activity shows up in another band, what is this an indication of?
- How often should a 24 hour urine test be done, what other sorts of tests should be done and how frequent do you recommend them?
- Is it possible to go back to using IV bortezomib (Velcade®) if there are more problems getting it subcutaneously?
- What can be done to control bone pain?
- What can be done to improve taste and smell that seem to be gone?
- Can you explain how the data is collected for more information about second cancers and Revlimid?
- Could you explain what the research shows about the role of zoledronic acid (Zometa®) or other bisphosphonates in sustaining remission?
- Is it possible right now for any patient to get the myeloma vaccination? If so, how? If not, when will it be available?
- What supplements and vitamins would you consider safe to take?
- With all the new chemotherapies available, is stem cell transplantation still a necessary step in the treatment strategy? Do you feel a person gains by having a stem cell transplant at some point in the process?
- Can you explain non-secretory myeloma?
- How common is it for myeloma to develop in family members?
- Could a kidney transplant be an option for a myeloma patient who is on dialysis three times a week?
- What drugs are used with a bone marrow transplant?
- How common is a relapse after a bone marrow transplant?
- What triggers a relapse after a patient has been in complete remission?
Sponsors and Supporters
This program was sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation, Millennium: The Takeda Oncology Company, and Onyx Pharmaceuticals, Inc.
